BLINK THERAPEUTICS
BLINK THERAPEUTICS
Industry:
Biotechnology Therapeutics
Total Employee:
11+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail
Similar Organizations
Minutia
Biotech, Therapeutics
Traxion Therapeutics Inc
Traxion Therapeutics Inc
Current Advisors List
More informations about "BliNK Therapeutics"
BliNK Therapeutics Ltd - Company Profile and News
Company profile page for BliNK Therapeutics Ltd including stock price, company news, executives, board members, and contact informationSee details»
BliNK Therapeutics Company Profile 2024: Valuation, Investors ...
BliNK Therapeutics has raised $2.58M. Who are BliNK Therapeutics’s investors? Cancer Research Horizons , Kurma Partners , and Stevenage Bioscience Catalyst have invested in …See details»
Valneva and BliNK Therapeutics confirm Launch and Funding of …
BliNK Therapeutics’ technology has been developed by Facundo Batista, Head of the Lymphocyte Interaction Laboratory at the London Research Institute, Cancer Research UK. The technology …See details»
BliNK Therapeutics | LinkedIn
BliNK Therapeutics develops a novel antibody discovery platform to generate therapeutic and diagnostic monoclonal antibodies towards clinically relevant targets. The platform technology …See details»
Valneva and BliNK Therapeutics Announce Launch of New Biotech …
Dec 11, 2014 Shareholders of BliNK Therapeutics Ltd will contribute their shares to the new company. Funds managed by Kurma Partners and Idinvest Partners will invest approximately …See details»
Valneva and BliNK Therapeutics confirm launch and funding of …
Jan 20, 2015 The new company is owned by Valneva, Kurma Biofund I (founding investor of BliNK Therapeutics), funds managed by Idinvest Partners, Cancer Research Technology …See details»
CRT and Kurma Biofund to develop new antibody platform for ...
Jun 13, 2011 BliNK Therapeutics will develop the novel platform to generate therapeutic and diagnostic monoclonal antibodies towards clinically relevant targets. The technology is based …See details»
BliNK Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore BliNK Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Valneva and BliNK Therapeutics Announce Launch of New
Dec 11, 2014 BliNK Therapeutics Ltd’s technology has been developed by Facundo Batista, Head of the Lymphocyte Interaction Laboratory at London Research Institute, Cancer …See details»
Valneva and BliNK Therapeutics Launch of New Biotech Company
Dec 15, 2014 Valneva SE and BliNK Therapeutics Ltd announced the creation of a private company specialized in the discovery of monoclonal antibodies to be headquartered in Lyon, …See details»
Valneva and BliNK Therapeutics Announce Launch of New Biotech …
Dec 11, 2014 Valneva and BliNK Therapeutics Announce Launch of New Biotech Company in Innovative Antibody Discovery New company has already secured first round of financing. …See details»
BliNK Therapeutics - Crunchbase Company Profile & Funding
Therapeutics Companies With Fewer Than 1000 Employees (Top 10K) 9,627 Number of Organizations • $261.4B Total Funding Amount • 16,347 Number of Investors TrackSee details»
BliNK Biomedical - Crunchbase Company Profile & Funding
BliNK Biomedical SAS specializes in the discovery and development of first or best-in-class antibody-based therapeutics for life threatening diseases such as cancer with a focus on …See details»
OS Therapies to develop BlinkBio next-generation Antibody
Aug 26, 2020 The potential for targeted delivery of small molecules, biologics, peptide therapeutics using this platform is unprecedented and holds tremendous promise,” added Dr. …See details»
BlinkBio - Crunchbase Company Profile & Funding
Organization. BlinkBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Therapeutics . Headquarters Regions Greater Miami …See details»
Valneva and Blink Therapeutics inaugurates Blink Biomedical
Jan 20, 2015 * Transaction of creating BliNK Biomedical is closed * Newly created company specialize in discovery of innovative monoclonal antibodies Source text for Eikon: Further …See details»
Woodbridge biotech gets FDA ‘orphan’ status for anti-tumor drug
Federal regulators have deemed a Woodbridge biotechnology company’s tumor-fighting therapy an ‘orphan’ drug, making it eligible for financial incentives. AlloMek Therapeutics earned the …See details»
Staff & Board - SCAN of Northern Virginia
Meet our board. At SCAN, we are committed to our mission.In order to help us fulfill that mission, we have gathered a team of committed professionals who represent excellence and integrity in …See details»
Kolm Therapeutics - PitchBook
Kolm Therapeutics’s primary industry is Biotechnology. Is Kolm Therapeutics a private or public company? Kolm Therapeutics is a Private company. What is Kolm Therapeutics’s current …See details»
Equinox Group - Wikipedia
Equinox Holdings, Inc. is an American luxury fitness company and health club headquartered in New York City, New York.The company operates more than 300 club facilities in major cities in …See details»